Literature DB >> 30817226

Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression.

Hee Kyung Kim1, Alvaro Baeza Garcia1, Edwin Siu1, Pathricia Tilstam1, Rita Das1,2, Scott Roberts1, Lin Leng1, Richard Bucala2.   

Abstract

T cells expressing invariant γδ antigen receptors (γδ T cells) bridge innate and adaptive immunity and facilitate barrier responses to pathogens. Macrophage migration inhibitory factor (MIF) is an upstream mediator of host defense that up-regulates the expression of pattern recognition receptors and sustains inflammatory responses by inhibiting activation-induced apoptosis in monocytes and macrophages. Surprisingly, Mif-/- γδ T cells, when compared with wild type, were observed to produce >10-fold higher levels of the proinflammatory cytokine IL-17 after stimulation with gram-positive exotoxins. High-IL-17 expression was associated with the characteristic features of IL-17-producing γδ T (γδ17) cells, including expression of IL-23R, IL-1R1, and the transcription factors RORγt and Sox13. In the gram-positive model of shock mediated by toxic shock syndrome toxin (TSST-1), Mif-/- mice succumbed to death more quickly with increased pulmonary neutrophil accumulation and higher production of cytokines, including IL-1β and IL-23. Mif-/- γδ T cells also produced high levels of IL-17 in response to Mycobacterium lipomannan, and depletion of γδ T cells improved survival from acutely lethal Mycobacterium infection or TSST-1 administration. These data indicate that MIF deficiency is associated with a compensatory amplification of γδ17 cell responses, with implications for innate immunity and IL-17-mediated pathology in situations such as gram-positive toxic shock or Mycobacterium infection.-Kim, H. K., Garcia, A. B., Siu, E., Tilstam, P., Das, R., Roberts, S., Leng, L., Bucala, R. Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression.

Entities:  

Keywords:  MIF; TSST-1

Year:  2019        PMID: 30817226      PMCID: PMC6529351          DOI: 10.1096/fj.201802433R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

Authors:  A R Satoskar; M Bozza; M Rodriguez Sosa; G Lin; J R David
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.

Authors:  John S Cho; Eric M Pietras; Nairy C Garcia; Romela Irene Ramos; David M Farzam; Holly R Monroe; Julie E Magorien; Andrew Blauvelt; Jay K Kolls; Ambrose L Cheung; Genhong Cheng; Robert L Modlin; Lloyd S Miller
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

5.  Accumulation of a potent gammadelta T-cell stimulator after deletion of the lytB gene in Escherichia coli.

Authors:  Matthias Eberl; Boran Altincicek; Ann-Kristin Kollas; Silke Sanderbrand; Ute Bahr; Armin Reichenberg; Ewald Beck; Donald Foster; Jochen Wiesner; Martin Hintz; Hassan Jomaa
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

6.  Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.

Authors:  Marije I Koenders; Erik Lubberts; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Monique M Helsen; Jay K Kolls; Leo A B Joosten; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2005-03

7.  Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.

Authors:  P Mombaerts; J Arnoldi; F Russ; S Tonegawa; S H Kaufmann
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

8.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

9.  Chemokine binding and activities mediated by the mouse IL-8 receptor.

Authors:  J Lee; G Cacalano; T Camerato; K Toy; M W Moore; W I Wood
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.

Authors:  Athina Savva; Matthijs C Brouwer; Thierry Roger; Mercedes Valls Serón; Didier Le Roy; Bart Ferwerda; Arie van der Ende; Pierre-Yves Bochud; Diederik van de Beek; Thierry Calandra
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more
  3 in total

1.  Macrophage migration inhibitory factor regulates TLR4 expression and modulates TCR/CD3-mediated activation in CD4+ T lymphocytes.

Authors:  Mohamed Alibashe-Ahmed; Thierry Roger; Veronique Serre-Beinier; Ekaterine Berishvili; Walter Reith; Domenico Bosco; Thierry Berney
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

2.  Restraint Stress in Hypertensive Rats Activates the Intestinal Macrophages and Reduces Intestinal Barrier Accompanied by Intestinal Flora Dysbiosis.

Authors:  Tiantian Wang; Lei Gao; Zejun Yang; Feifei Wang; Yuexin Guo; Boya Wang; Rongxuan Hua; Hongwei Shang; Jingdong Xu
Journal:  J Inflamm Res       Date:  2021-03-25

Review 3.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.